Chronic kidney disease: A public health problem that needs a public health action plan

Preventing Chronic Disease

Volumn 3, Issue 2, 2006, Pages 1-6

  Schoolwerth, Anton C ^a,b   Engelgau, Michael M ^b   Hostetter, Thomas H ^c   Rufo, Kathy H ^b   Chianchiano, Dolph ^d   McClellan, William M ^e   Warnock, David G ^f   Vinicor, Frank ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL KIDNEY FOUNDATION   (United States)

^e EMORY UNIVERSITY   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84978654081     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Vinicor F. Is diabetes a public-health disorder? Diabetes Care 1994;17(Suppl 1):22-7.
2. Saaddine JB, Narayan KM, Vinicor F. Vision loss: a public health problem? Ophthalmology 2003;110(2):253-4.
3. US Renal Data System. USRDS 2004 Annual Data Report. Atlas of end-stage renal disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004. Available from: URL: http://www.usrds.org/atlas_2004.htm.
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41(1):1-12.
5. US Renal Data System. USRDS 2003 Annual Data Report. Atlas of end-stage renal disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003. Available from: URL: http://www.usrds.org/atlas_2003.htm.
6. Merrill RM, Kessler LG, Udler JM, Rasband GC, Feuer EJ. Comparison of risk estimates for selected diseases and causes of death. Prev Med 1999;28(2):179-93.
7. Kiberd BA, Clase CM. Cumulative risk for developing end-stage renal disease in the US population. J Am Soc Nephrol 2002;13(6):1635-44.
8. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001;12(12):2753-8.
9. Gilbertson D, Solid C, Xue JL, Collins AJ. Projecting the U.S. ESRD population by 2030. US Renal Data System: Data presented at the 2003 American Society of Nephrology Annual Meeting. Available from: URL: http://www.usrds.org/2003/pres/html/5U_ASN_projections_files/frame.htm.
10. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108(17):2154-69.
11. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003;63(3):1121-9.
12. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296-305.
13. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. [Published erratum in: JAMA 2005 Jan 19;293(3): 293-4]. JAMA 2004;291(10):1238-45.
14. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164(6):659-63.
15. Menon V, Sarnak MJ. The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination. Am J Kidney Dis 2005;45(1):223-32.
16. Hunsicker LG. The consequences and costs of chronic kidney disease before ESRD. J Am Soc Nephrol 2004;15(5):1363-4.
17. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39(2 Suppl 1): S1-266.
18. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, et al. Nephropathy in diabetes. Diabetes Care 2004;27(Suppl 1): S79-83.
19. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, et al. Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 2003;42(4):617-22.
20. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003;290(23):3101-14.
21. de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 2004;66(6):2109-18.
22. Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004;66(2):753-60.
23. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106(14):1777-82.
24. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Lond) 1995;88(6):629-33.
25. Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004;110(18):2809-16.
26. McClellan WM, Knight DF, Karp H, Brown WW. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am J Kidney Dis 1997;29(3):368-75.
27. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 1999;10(8):1793-800.
28. Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol 2001;12(8):1713-20.
29. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16(1):180-8.
30. Parker TF 3rd, Blantz R, Hostetter T, Himmelfarb J, Kliger A, Lazarus M, et al. The chronic kidney disease initiative. J Am Soc Nephrol 2004;15(3):708-16.
31. Hostetter TH, Lising M. National Kidney Disease Education Program. J Natl Med Assoc 2002;94(8 Suppl):72S-5.